The Way of the VC 风险投资之道

Qian Yu

Principal / Shanghai Office Chief Representative

Download Podcast

Qian Yu joined Fidelity Asia Ventures in 2004. She focuses on investments in the communications, Internet, media and emerging technologies & services.

Prior to Fidelity, Yu spent 5 years in the telecommunications industry. From 1997 to 2002, Yu gained extensive knowledge and experience at Huawei Technologies where she took managerial roles in various departments including marketing, R&D and business development. She also worked in Optech, a telecommunications start-up as director of sales and marketing in 2002.

Yu received her MBA degree from the Wharton School of Business. She holds M.S in engineering from Tsinghua University and B.S in engineering from Zhejiang University.


About Fidelity Asia Ventures

Introduction

Fidelity Asia Ventures (FAV) is the Asian venture capital arm of FIL Limited.

At Fidelity Asia Ventures our mission is to invest principally in high-quality, high-growth companies in the Asian information technology and healthcare sectors, focusing primarily on opportunities in China.

We have offices in Hong Kong, Beijing and Shanghai, and a successful track record of investing in leading companies in the region, particularly China, over the past 14 years.
Global Resources and Reputation

As one of the largest mutual fund organisations in the world, Fidelity is an affiliation of two separate, privately owned companies: FMR LLC in the United States and FIL Limited outside the United States. Fidelity has operations in over 35 countries and over 21 million customers, bringing significant global resources and expertise to its Asian venture capital activities.

In the US, Fidelity Ventures invests in technology companies at the "Go-To-Market" stage. Its 40-year track record includes hundreds of successful investments including industry leaders like Atari, Continental Cablevision, MCI, Nextel, Teleport Communications and ROLM.

Fidelity Biosciences, based in Cambridge, has a diverse portfolio of promising early-stage biopharmaceutical and medical technology companies, including EnVivo Pharmaceuticals, FoldRx, Mersana Therapeutics, Microbia and US Genomics.

In addition to its capital and brand name, Fidelity has a range of strategic capabilities and assets that contribute to its venture activities. The Fidelity organisation spends over US $2.5 billion a year on technology and related business process initiatives and acts as a strong early-adopter for several of its venture capital portfolio companies. Furthermore, Fidelity has founded and backed leading telecommunications companies in Europe, Japan and South America including COLT Telecom and KVH Telecom. In turn, these regional carriers have become valuable customers and partners to other Fidelity-backed companies.

Globally, the Fidelity brand stands for deep commitment, contribution and integrity in all of its investment activities. Fidelity actively seeks ways to leverage its global information technology and life sciences expertise through its venture capital activities.
Asian Expertise and Track Record

Fidelity Asia Ventures has actively invested in both the information technology and healthcare sectors in Asia for more than a decade.

We typically invest in a company at an early stage and devote tremendous time and energy working with entrepreneurs to maximize their success. Portfolio companies in the past include: Alibaba, Hurray (NASDAQ: HRAY), AsiaInfo (NASDAQ: ASIA), Dianji Technology, Wuxi Pharmatech, Zhongsou and Asia Renal Care. We typically invest between US $2 and 10 million per round and are active Board members for the companies.

Our investment team in Hong Kong, Beijing and Shanghai has decades of experience in the Asia-Pacific region. Additionally, we have significant operational and entrepreneurial capabilities and understand both the excitement and the challenges of running businesses in China and other growing Asian markets.

We look forward to talking to dynamic entrepreneurs about utilizing Fidelity's extensive global resources and deep local expertise to maximize the success of their companies.